Publikace
- Combined Therapeutic Modality with Rituximab, Fludarabin and Cyclophosphamide Followed by High Dose Therapy with Autologous Stem Cell Transplantation (ASCT) Leads to Excellent Response Rate and High Probability of Molecular Remission in Chronic Lymphocytic Leukemia (CLL) PatientsPublikace bez příslušnosti k fakultě
- Cell Dysplasia - Cell Dysplastic Features (A Morphological Note)2023 | 1. lékařská fakulta
- The Reduction of the Cell Nuclear Size in the Cell Body Space During the Differentiation Might Be Cell Lineage Specific (A Retrospective Morphological Note)2023 | 1. lékařská fakulta
- Polatuzumab vedotin plus bendamustine and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma in the real world2022 | 1. lékařská fakulta, Lékařská fakulta v Hradci Králové, 3. lékařská fakulta, Lékařská fakulta v Plzni
- RNA Concentration and Content in the Nucleoli and Cytoplasmic Rim in Differentiating Lymphocytes of Patients Suffering from B Chronic Lymphocytic Leukaemia - a Cytochemical Note2022 | 1. lékařská fakulta
- CD31/PECAM-1 impacts engraftment, growth and spread of mantle cell lymphoma cells and positively correlates with extramedullary involvement2021 | 1. lékařská fakulta
- The Cell Body Space Occupied by the Nucleus During the Cell Differentiation in Human Lymphocytic, Granulocytic and Erythroid Cell Lineages2021 | 1. lékařská fakulta
- Prospective observational study in comorbid patients with chronic lymphocytic leukemia receiving first-line bendamustine with rituximab2019 | 1. lékařská fakulta, Lékařská fakulta v Hradci Králové, 3. lékařská fakulta
- 18F-FDG PET/CT obraz Erdheimovy-Chesterovy nemoci - přehled českých pacientů2018 | 1. lékařská fakulta
- Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II study2015 | Lékařská fakulta v Hradci Králové
Loading network view...